S&P 500   4,362.94 (-1.07%)
DOW   34,309.63 (-0.16%)
QQQ   346.37 (-1.96%)
AAPL   161.38 (-0.15%)
MSFT   291.90 (-1.51%)
FB   303.71 (-1.62%)
GOOGL   2,566.74 (-1.89%)
AMZN   2,812.08 (-2.73%)
TSLA   934.49 (+0.48%)
NVDA   226.02 (-3.29%)
BABA   120.33 (-0.03%)
NIO   24.08 (-3.18%)
AMD   112.34 (-3.60%)
CGC   7.42 (+0.27%)
MU   81.30 (-1.99%)
GE   91.42 (-5.67%)
T   26.48 (+0.53%)
F   20.14 (-1.23%)
DIS   137.09 (-0.27%)
AMC   16.21 (-2.58%)
PFE   52.46 (+1.79%)
ACB   4.24 (-1.85%)
BA   204.74 (+0.26%)
S&P 500   4,362.94 (-1.07%)
DOW   34,309.63 (-0.16%)
QQQ   346.37 (-1.96%)
AAPL   161.38 (-0.15%)
MSFT   291.90 (-1.51%)
FB   303.71 (-1.62%)
GOOGL   2,566.74 (-1.89%)
AMZN   2,812.08 (-2.73%)
TSLA   934.49 (+0.48%)
NVDA   226.02 (-3.29%)
BABA   120.33 (-0.03%)
NIO   24.08 (-3.18%)
AMD   112.34 (-3.60%)
CGC   7.42 (+0.27%)
MU   81.30 (-1.99%)
GE   91.42 (-5.67%)
T   26.48 (+0.53%)
F   20.14 (-1.23%)
DIS   137.09 (-0.27%)
AMC   16.21 (-2.58%)
PFE   52.46 (+1.79%)
ACB   4.24 (-1.85%)
BA   204.74 (+0.26%)
S&P 500   4,362.94 (-1.07%)
DOW   34,309.63 (-0.16%)
QQQ   346.37 (-1.96%)
AAPL   161.38 (-0.15%)
MSFT   291.90 (-1.51%)
FB   303.71 (-1.62%)
GOOGL   2,566.74 (-1.89%)
AMZN   2,812.08 (-2.73%)
TSLA   934.49 (+0.48%)
NVDA   226.02 (-3.29%)
BABA   120.33 (-0.03%)
NIO   24.08 (-3.18%)
AMD   112.34 (-3.60%)
CGC   7.42 (+0.27%)
MU   81.30 (-1.99%)
GE   91.42 (-5.67%)
T   26.48 (+0.53%)
F   20.14 (-1.23%)
DIS   137.09 (-0.27%)
AMC   16.21 (-2.58%)
PFE   52.46 (+1.79%)
ACB   4.24 (-1.85%)
BA   204.74 (+0.26%)
S&P 500   4,362.94 (-1.07%)
DOW   34,309.63 (-0.16%)
QQQ   346.37 (-1.96%)
AAPL   161.38 (-0.15%)
MSFT   291.90 (-1.51%)
FB   303.71 (-1.62%)
GOOGL   2,566.74 (-1.89%)
AMZN   2,812.08 (-2.73%)
TSLA   934.49 (+0.48%)
NVDA   226.02 (-3.29%)
BABA   120.33 (-0.03%)
NIO   24.08 (-3.18%)
AMD   112.34 (-3.60%)
CGC   7.42 (+0.27%)
MU   81.30 (-1.99%)
GE   91.42 (-5.67%)
T   26.48 (+0.53%)
F   20.14 (-1.23%)
DIS   137.09 (-0.27%)
AMC   16.21 (-2.58%)
PFE   52.46 (+1.79%)
ACB   4.24 (-1.85%)
BA   204.74 (+0.26%)
NASDAQ:BYSI

BeyondSpring News Headlines

$3.37
+0.08 (+2.43%)
(As of 01/25/2022 03:38 PM ET)
Add
Compare
Today's Range
$3.16
$3.40
50-Day Range
$3.28
$14.35
52-Week Range
$2.91
$33.00
Volume
30,256 shs
Average Volume
912,517 shs
Market Capitalization
$131.79 million
P/E Ratio
N/A
Dividend Yield
N/A
Beta
0.86
Get BeyondSpring News Delivered to You Automatically

Sign up to receive the latest news and ratings for BYSI and its competitors with MarketBeat's FREE daily newsletter.

Media Mentions By Week

BeyondSpring Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

BYSI
News Sentiment

0.54

0.35

Average
Medical
News Sentiment

Media Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

BYSI Articles
This Week

0

4

BYSI Articles
Average Week



BeyondSpring (NASDAQ:BYSI) News Headlines Today

SourceHeadline
benzinga.com logoThe Daily Biotech Pulse: Biogen Slumps As CMS Announces Restrictive Coverage For Aduhelm, Aclaris CMO Dep - Benzinga
benzinga.com - January 12 at 2:31 PM
streetinsider.com logoBeyondSpring (BYSI) Announces Organizational Streamlining - StreetInsider.com
streetinsider.com - January 12 at 2:31 PM
benzinga.com logoBeyondSpring Cuts On-Third Of Its Workforce - Benzinga - Benzinga
benzinga.com - January 12 at 9:31 AM
finance.yahoo.com logoBeyondSpring Cuts On-Third Of Its Workforce
finance.yahoo.com - January 12 at 9:30 AM
seekingalpha.com logoBeyondSpring Pharmaceuticals cuts 35% of its U.S. workforce - Seeking Alpha
seekingalpha.com - January 11 at 6:20 PM
globenewswire.com logoBeyondSpring Announces Organizational Streamlining - GlobeNewswire
globenewswire.com - January 11 at 6:20 PM
finance.yahoo.com logoBeyondSpring Announces Organizational Streamlining
finance.yahoo.com - January 11 at 6:19 PM
streetinsider.com logoVaxxinity, Inc (VAXX) Appoints George Hornig to its Board, Jason Pesile as SVP - StreetInsider.com
streetinsider.com - January 4 at 9:41 AM
finance.yahoo.com logoBeyondSpring Inc. (BYSI) Reports Q3 Loss, Lags Revenue Estimates
finance.yahoo.com - December 30 at 12:28 PM
finance.yahoo.com logoBeyondSpring, Inc. Investigated by Block & Leviton For Potential Securities Law Violations; Investors Who Have Lost Money Are Encouraged to Contact the Firm - Yahoo Finance
finance.yahoo.com - December 28 at 11:33 PM
finance.yahoo.com logoBeyondSpring's New Plinabulin Data Shows Fast Onset In Preventing Chemo-Induced Neutropenia
finance.yahoo.com - December 15 at 6:09 PM
finance.yahoo.com logoSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors BeyondSpring Inc. - BYSI - Yahoo Finance
finance.yahoo.com - December 15 at 1:08 PM
finance.yahoo.com logoBeyondSpring Pharmaceuticals Announces New Clinical Data Confirming Plinabulin’s Fast Onset Mechanism of Action in the Prevention of Chemotherapy-Induced Neutropenia at the 63rd ASH Annual Meeting and Exposition - Yahoo Finance
finance.yahoo.com - December 15 at 1:08 PM
finance.yahoo.com logoSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors BeyondSpring Inc. - BYSI
finance.yahoo.com - December 14 at 8:26 PM
globenewswire.com logoBeyondSpring Pharmaceuticals Announces Analysis of New Data - GlobeNewswire
globenewswire.com - December 10 at 8:48 AM
finance.yahoo.com logoBeyondSpring Pharmaceuticals Announces Analysis of New Data on the Plinabulin/Pegfilgrastim Combination in Breast Cancer at the 2021 San Antonio Breast Cancer Symposium
finance.yahoo.com - December 10 at 8:48 AM
finance.yahoo.com logoSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of BeyondSpring Inc. - BYSI
finance.yahoo.com - December 6 at 9:10 PM
finance.yahoo.com logoBeyondSpring: Not Beyond Hope Yet, Says Analyst
finance.yahoo.com - December 3 at 8:53 AM
finance.yahoo.com logoSHAREHOLDER ALERT: Investigation of BeyondSpring, Inc. Announced by Holzer & Holzer, LLC
finance.yahoo.com - December 2 at 7:43 PM
globenewswire.com logoBeyondSpring, Inc. Investigated by Block & Leviton For Potential Securities Law Violations - GlobeNewswire
globenewswire.com - December 2 at 2:43 PM
seekingalpha.com logoHot Stocks: Omicron airline woes; vaccine patent dispute; AMBA, BBW rally on earnings; BYSI plunges - Seeking Alpha
seekingalpha.com - December 1 at 11:10 PM
finance.yahoo.com logoBronstein, Gewirtz & Grossman, LLC Notifies Shareholders of BeyondSpring Inc. (BYSI) Investigation
finance.yahoo.com - December 1 at 6:10 PM
benzinga.com logoMid-Day Market Update: Build-A-Bear Jumps After Q3 Results; BeyondSpring Shares Slide - Benzinga
benzinga.com - December 1 at 1:09 PM
marketwatch.com logoBeyondSpring's NDA for CIN treatment 'cannot be approved' in current form, FDA says - MarketWatch
marketwatch.com - December 1 at 1:09 PM
reuters.com logoU.S. FDA declines to approve BeyondSpring's neutropenia drug, shares plunge - Reuters
reuters.com - December 1 at 1:09 PM
finance.yahoo.com logoBeyondSpring Pharmaceuticals Receives Complete Response Letter from the FDA for Plinabulin New Drug Application for Prevention of Chemotherapy-Induced Neutropenia (CIN)
finance.yahoo.com - December 1 at 1:09 PM
finance.yahoo.com logoBeyondSpring, Inc. Investigated by Block & Leviton For Potential Securities Law Violations; Investors Who Have Lost Money Are Encouraged to Contact the Firm
finance.yahoo.com - December 1 at 1:09 PM
globenewswire.com logoBeyondSpring Pharmaceuticals Receives Complete Response - GlobeNewswire
globenewswire.com - December 1 at 8:09 AM
benzinga.com logoLongeveron Announces Clinical Collaboration To Study Cell Therapy Aging Treatment In Japan: Why It Matters - Benzinga
benzinga.com - November 30 at 8:05 PM
seekingalpha.com logoBeyondSpring, CTI BioPharma gain ahead of FDA decision for key drugs - Seeking Alpha
seekingalpha.com - November 30 at 9:57 AM
benzinga.com logo3 Pharma Stocks Morgan Stanley Says Will Be Omicron Variant Beneficiaries - Benzinga - Benzinga
benzinga.com - November 29 at 5:30 PM
benzinga.com logoThe Week Ahead In Biotech (Nov. 28-Dec. 4): FDA Decisions For VBI Vaccines, BeyondSpring, CTI Biopharma And Merck Take The Spotlight In A Light Calendar Week - Benzinga
benzinga.com - November 28 at 10:11 AM
seekingalpha.com logoCOVID-19 vaccine stocks surge on worries over new variant - Seeking Alpha
seekingalpha.com - November 26 at 9:58 AM
globenewswire.com logoBeyondSpring Pharmaceuticals to Present at the 4th Annual - GlobeNewswire
globenewswire.com - November 24 at 3:04 PM
finance.yahoo.com logoBeyondSpring Pharmaceuticals to Present at the 4th Annual Evercore ISI HealthCONx Conference
finance.yahoo.com - November 24 at 10:03 AM
finance.yahoo.com logoRafael Holdings Realigns Leadership Team to Support Earlier Stage Pipeline Focus - Yahoo Finance
finance.yahoo.com - November 22 at 9:47 AM
seekingalpha.com logoCircling Back On BeyondSpring - Seeking Alpha
seekingalpha.com - November 16 at 8:26 PM
finance.yahoo.com logoBeyondSpring Pharmaceuticals to Present at the 2021 Jefferies London Healthcare Conference - Yahoo Finance
finance.yahoo.com - November 12 at 9:32 AM
finance.yahoo.com logoBeyondSpring Pharmaceuticals to Present at the 2021 Jefferies London Healthcare Conference
finance.yahoo.com - November 12 at 9:32 AM
finance.yahoo.com logoBeyondSpring Appoints Commercial Leader Mark Santos to its Board of Directors - Yahoo Finance
finance.yahoo.com - November 10 at 2:11 PM
globenewswire.com logoBeyondSpring Appoints Commercial Leader Mark Santos to its - GlobeNewswire
globenewswire.com - November 10 at 9:10 AM
finance.yahoo.com logoBeyondSpring Appoints Commercial Leader Mark Santos to its Board of Directors
finance.yahoo.com - November 10 at 9:10 AM
finance.yahoo.com logo3 Biotech Stocks With Huge Catalysts Incoming
finance.yahoo.com - October 30 at 4:09 AM
ft.com logoUK MPs slam test and trace programme's 'eye-watering' spending - Financial Times
ft.com - October 27 at 10:55 AM
finance.yahoo.com logoBeyondSpring Announces First Patient Treated in Phase 2 Study with Plinabulin Combined with Nivolumab + Ipilimumab in Patients in 3rd Line Recurrent Small-Cell Lung Cancer Patients Who Failed Checkpoint Inhibitors - Yahoo Finance
finance.yahoo.com - October 21 at 11:36 PM
globenewswire.com logoBeyondSpring Announces First Patient Treated in Phase 2 - GlobeNewswire
globenewswire.com - October 21 at 1:35 PM
finance.yahoo.com logoBeyondSpring Announces First Patient Treated in Phase 2 Study with Plinabulin Combined with Nivolumab + Ipilimumab in Patients in 3rd Line Recurrent Small-Cell Lung Cancer Patients Who Failed Checkpoint Inhibitors
finance.yahoo.com - October 21 at 8:34 AM
finance.yahoo.com logoBeyondSpring Pharmaceuticals Announces New Patient-Derived Cancer Model Data for Plinabulin Monotherpy at the AACR-NCI-EORTC Virtual International Conference to Further Support the Positive Clinical Data Already Reported for the Treatment of Smal - Yahoo Finance
finance.yahoo.com - October 20 at 7:31 AM
finance.yahoo.com logoBeyondSpring Pharmaceuticals Announces New Patient-Derived Cancer Model Data for Plinabulin Monotherpy at the AACR-NCI-EORTC Virtual International Conference to Further Support the Positive Clinical Data Already Reported for the Treatment of Small Cell Lung Cancer
finance.yahoo.com - October 20 at 7:31 AM
nasdaq.com logoInvesting in Cara Therapeutics (NASDAQ:CARA) five years ago would have delivered you a 69% gain - Nasdaq
nasdaq.com - October 15 at 2:09 PM
Get BeyondSpring News Delivered to You Automatically

Sign up to receive the latest news and ratings for BYSI and its competitors with MarketBeat's FREE daily newsletter.

This page was last updated on 1/25/2022 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.